Morphic Holding, Inc. (45) | Business Operations (9)

Browse by Subcategory

Collaboration Agreements (9)

Recent Contracts

Amendment No. 2 to Research Collaboration and Option Agreement, dated as of June 18, 2021, by and between the Registrant and Janssen Pharmaceuticals, Inc (Filed With SEC on August 4, 2021)
Amendment No. 1 to the Research Collaboration and Option Agreement, dated December 30, 2020, by and among Janssen Pharmaceuticals, Inc. and the Registrant (Filed With SEC on March 1, 2021)
Collaboration and Option Agreement, dated October 16, 2018, by and between AbbVie Biotechnology Ltd and the Registrant (Filed With SEC on June 24, 2019)
Collaboration Agreement, dated June 10, 2015, by and between Morphic Rock Therapeutic, Inc. and Schrdinger, LLC, as amended (Filed With SEC on June 14, 2019)
Research Collaboration and Option Agreement, dated February 15, 2019, by and among Janssen Pharmaceuticals, Inc. and the Registrant (Filed With SEC on June 14, 2019)
Collaboration and Option Agreement, dated October 16, 2018, by and between AbbVie Biotechnology Ltd and the Registrant (Filed With SEC on June 14, 2019)
Collaboration Agreement, dated June 10, 2015, by and between Morphic Rock Therapeutic, Inc. and Schrdinger, LLC, as amended (Filed With SEC on May 30, 2019)
Research Collaboration and Option Agreement, dated February 15, 2019, by and among Janssen Pharmaceuticals, Inc. and the Registrant (Filed With SEC on May 30, 2019)
Collaboration and Option Agreement, dated October 16, 2018, by and between AbbVie Biotechnology Ltd and the Registrant (Filed With SEC on May 30, 2019)